24 results
8-K
0g8 aa8ju2h8mynq6c
29 Sep 22
GB2064 Shows Reduction in Fibrosis of the Bone Marrow in Patients with Myelofibrosis, Validating LOXL2 as a Clinical Fibrosis Target
7:00am
8-K
EX-99.1
7nrdahtv7tnexyiykp8j
29 Sep 22
GB2064 Shows Reduction in Fibrosis of the Bone Marrow in Patients with Myelofibrosis, Validating LOXL2 as a Clinical Fibrosis Target
7:00am
S-3
EX-4.4
l6ainsf6q
4 Nov 21
Shelf registration
4:59pm
S-3
EX-4.3
57k0gnf
4 Nov 21
Shelf registration
4:59pm
S-3
EX-1.2
19030t
4 Nov 21
Shelf registration
4:59pm
10-K
unre54mcy
29 Mar 21
Annual report
6:03am
10-K
EX-10.2
den7bbsff02f aj40
29 Mar 21
Annual report
6:03am
10-Q
rdgk5sic8qerd 47kll
11 Dec 20
Quarterly report
7:30am
424B4
udmvqm2pg4xw4pzjzsw
30 Oct 20
Prospectus supplement with pricing info
4:31pm
S-1/A
inxr rlw2
22 Oct 20
IPO registration (amended)
6:13am
S-1/A
EX-1.1
yol e8xqsn0m44n
22 Oct 20
IPO registration (amended)
6:13am
S-1/A
EX-4.2
6kuf4
22 Oct 20
IPO registration (amended)
6:13am
CORRESP
tn7gjz26fs6z6
13 Oct 20
Correspondence with SEC
12:00am